We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of Cookies, Privacy Policy Term of use.
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
168 views • January 12, 2023

China to Remove Paxlovid From Insurance Drug List

NTD News
NTD News
With demand for antiviral drugs skyrocketing amid the COVID-19 outbreak in China, the CCP says it will remove a certain medication from its health insurance drug list in April. The targeted drug is called Paxlovid— an antiviral made by U.S. drug maker Pfizer. Chinese authorities attributed the removal to a high price for the COVID-19 drug quoted by the U-S firm.
Show All
Comment 0